Abiopharma

🔍 Giglietti Robert M. (Executive)

Company: GENERAL ELECTRIC CO (GE)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 773 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 19,264.00 | transaction_form_type: 4
• Sold 359 shares of Common Stock at $286.51 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 18,905.00 | transaction_form_type: 4
• Acquired 2,416 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 21,321.00 | transaction_form_type: 4
• Sold 1,120 shares of Common Stock at $286.51 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 20,201.00 | transaction_form_type: 4
• Sold 773 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 773.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 2,416 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,416.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock.
• F2: The Restricted Stock Units were granted on May 1, 2024, and vest in two equal installments of 50% each, on the second and third anniversary of the grant date.